Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 255Rectal Neoplasms 155Colonic Neoplasms 128Stomach Neoplasms 100Pancreatic Neoplasms 94Breast Neoplasms 77Esophageal Neoplasms 76Neoplasm Metastasis 58Squamous Cell Carcinoma of Head and Neck 56Head and Neck Neoplasms 56Neoplasms 43Adenocarcinoma Of Esophagus 37Esophageal Squamous Cell Carcinoma 27Adenocarcinoma 25Unspecified Adult Solid Tumor, Protocol Specific 15Carcinoma, Hepatocellular 15Parkinson Disease 4, Autosomal Dominant Lewy Body 13Anus Neoplasms 12Keratosis, Actinic 11Gastrointestinal Neoplasms 11Biliary Tract Neoplasms 11Gallbladder Neoplasms 10Carcinoma, Squamous Cell 10Urinary Bladder Neoplasms 9Nasopharyngeal Carcinoma 9Liver Neoplasms 9Cholangiocarcinoma 9Carcinoma 9Bile Duct Neoplasms 9Recurrence 8

Interventions

motexafin gadolinium 1Talaporfin 1Radiosurgery 1Poly I-C 1Gadolinium 1Folfox protocol 1Fluorouracil 1Erlotinib Hydrochloride 1Docetaxel 1Cisplatin 1Bevacizumab 1Anesthesia, General 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neoplasm Recurrence, Local × Fluorouracil × Clear all
NCT00401323 2011-01-20

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Sanofi

Phase 2/3 Completed
568 enrolled
Head & Neck

Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasm Recurrence, Local

Data powered by HemOnc (CC BY 4.0) Colophon âš¡